Healthcare and Pharmaceuticals industry

Global Adult Vaccines Market Size Share Forecast 2024




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Vaccination and immunization is aids in prevention of diseases among adults and children. Vaccines are biological suspensions that contain an agent that resembles the disease causing microorganisms and are often made from inactivated microbes, toxins or surface proteins. The active agents present in the vaccine stimulates body’s immune system to recognize the disease causing agent as 'foreign substance' and develop antibodies against it. Vaccines are a preferable and highly recommended preventive measure against certain severe diseases, however, have mild side effects.
Market Dynamics
Development of vaccines for various new diseases and rising awareness regarding advantages of preventive medication are the two prominent factors supporting growth of the market. For instance, according to the Centers for Disease Control and Prevention, 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden. However, high complexity in cost of manufacturing a vaccine is one of the major factors negatively affecting growth of the market.
Key features of the study:

This report provides in-depth analysis of adult vaccines market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global adult vaccines market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study includes GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer, Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, and AstraZeneca Plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the adult vaccines market

Detailed Segmentation:

Global Adult Vaccines Market, By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

Global Adult Vaccines Market, By Vaccine Type:

Monovalent
Multivalent

Global Adult Vaccines Market, By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

Global Adult Vaccines Market, By Geography:

North America

By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type:

Monovalent
Multivalent

By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

By Country:

U.S.
Canada


Latin America

By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type:

Monovalent
Multivalent

By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

By Country:

Brazil
Mexico
Argentina
Rest of Latin America


Europe

By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type:

Monovalent
Multivalent

By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe


Asia Pacific

By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type:

Monovalent
Multivalent

By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific


Middle East

By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type:

Monovalent
Multivalent

By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

By Country:

GCC
Israel
Rest of Middle East


Africa

By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type:

Monovalent
Multivalent

By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

By Country:

South Africa
Central Africa
North Africa



Company Profiles

GlaxoSmithKline Plc *

Company Overview
Product Portfolio
Key Highlights
Financial Performance
Strategies

Merck & Co., Inc.
Sanofi Pasteur
Pfizer, Inc.
CSL Limited
Johnson & Johnson
Serum Institute of India
Medimmune
AstraZeneca Plc


“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Vaccine
? Market Snippet, By Vaccine Type
? Market Snippet, By Technology
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Key Highlights
o Market Trends
o PEST Analysis
o Government & Non-Government Initiatives
o Epidemiology
4. Global Adult Vaccines Market, By Vaccine, 2015 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2016 - 2025
? Segment Trends
o Influenza
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Tetanus, Diphtheria, Pertussis (Td/Tdap)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Varicella
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Human Papillomavirus
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Zoster
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Measles, Mumps, Rubella (MMR)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Pneumococcal
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Hepatitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
5. Global Adult Vaccines Market, By Vaccine Type, 2015 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2016 - 2025
? Segment Trends
o Monovalent
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Multivalent
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
6. Global Adult Vaccines Market, By Technology, 2015 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2016 - 2025
? Segment Trends
o Live Attenuated Vaccines
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Inactivated Viral/Bacterial Vaccines
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Toxoid Vaccines
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Recombinant Vaccines
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Conjugate Vaccines
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
7. Global Adult Vaccines Market, By Region, 2017 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, For Region, 2016 - 2025
o North America
? Market Size and Forecast, By Vaccine, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Vaccine Type, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? U.S.
? Canada
o Latin America
? Market Size and Forecast, By Vaccine, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Vaccine Type, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? Brazil
? Mexico
? Argentina
? Rest of Latin America
o Europe
? Market Size and Forecast, By Vaccine, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Vaccine Type, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Vaccine, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Vaccine Type, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of APAC
o Middle East
? Market Size and Forecast, By Vaccine, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Vaccine Type, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? GCC
? Israel
? Rest of Middle East
o Africa
? Market Size and Forecast, By Vaccine, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Vaccine Type, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? South Africa
? Central Africa
? North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profiles
? GlaxoSmithKline Plc
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? Merck & Co., Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? Sanofi Pasteur
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? Pfizer, Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? CSL Limited
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? Johnson & Johnson
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? Serum Institute of India
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? Medimmune
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? AstraZeneca Plc
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
9. Section
o Analyst Views
10. Section
o References
o Research Methodology
o About Uus and Sales Contact
*Browse 34 market data tables and 38 figures on "Adult Vaccines Market - Global forecast to 2025".
 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.